GEA supplies a comprehensive variety of standard and custom-built freeze dryers for the commercial-scale production of high-quality pharmaceutical products.
Fully automated and GMP-compliant, our portfolio of modular equipment ranges from standalone production plant to multi-floor, high-capacity systems as well as ALUS™ (Automatic Loading and Unloading System), integrated isolators and CIP-skids.
We also supply sophisticated solutions for highly potent products and fully integrated systems with multiple freeze dryers and loading systems that are compatible with third-party filling lines, cleanrooms and isolators.
The design and manufacture of each module and system component is done in accordance with all cGMP, CE, GAMP, ASME-BPE and 21 CFR Part 11 guidelines, meeting the strictest requirements and regulatory standards around the world.
In addition, the company’s retrofit expertise enables customers to extend the life of their freeze dryers, modernize their production lines, cope with changing regulations and comply with current requirements for environmentally friendly processing.
By ensuring security of outcome and batch safety, GEA lyophilizers help to reduce the cost of freeze drying while maintaining quality and performance, making validation and documentation easier and reducing delivery times.

Showing 4 of 10

ALUS® Automatic Load & Unload Systems minimize the risk of operator/product contamination while loading and unloading a freeze dryer.

LYOSENSE® from GEA, based on multipoint NIR measurements, provides the comprehensive and non-destructive evaluation of freeze-dried product cakes in real-time.

A novel approach to simple, reliable and easily controlled nucleation during industrial freeze drying

Freeze dryers are typically associated with high levels of energy consumption. To counteract this issue, GEA Pharma & Healthcare has introduced the LYOVAC® ECO Mode.
GEA centrifuges enable wastewater reuse, resource recovery, and water security by turning biosolids into value in a world facing growing water scarcity.
Last year was not a year of hyped-up headlines for alternative proteins. Perhaps that is precisely why it was an important year for food biotech, the biotechnology behind everyday foods and ingredients. While the sector worked through a difficult funding environment, approvals were still granted, pilot lines set up and new platforms tested in the background. In short: headlines are turning into infrastructure. Frederieke Reiners heads GEA’s New Food business. She and her team work at the intersection of biotechnology and industrial food production. In this interview, she takes us on a world tour of food biotech in seven questions.
Pets are family – and owners expect premium, transparent and sustainable nutrition. Freeze-drying, powered by GEA technology, helps pet food makers deliver.